MicroRNAs (miRNAs) are a group of small non‐coding RNAs that are involved in regulating
a range of developmental and physiological processes; their dysregulation has been …

Breast cancer is the second most common malignancy diagnosed in women, supporting the
need for identification of novel prognostic and diagnostic biomarkers. Recently, microRNAs …

Recent studies have demonstrated that long non-coding RNAs (lncRNAs) are regarded as
useful tools for cancer detection, particularly for the early stage; however, little is known …

Despite the development of combined modality treatments against liposarcoma in recent
years, a significant proportion of patients respond only modestly to such approaches …

microRNAs have emerged as powerful regulators of many biological processes, and their
expression in many cancer tissues has been shown to correlate with clinical parameters …

BACKGROUND: Long non-coding RNA (lncRNA) H19 has been well studied playing an
important role in breast cancer (BC) progress and the expression of H19 may service as a …

The relatively new field of microRNA (miR) has experienced rapid growth in methodology
associated with its detection and bioanalysis as well as with its role in-omics research …

In-depth insights in cancer biology over the past decades have highlighted the important
roles of epigenetic mechanisms in the initiation and progression of tumorigenesis. The …

Predictive, preventive, and personalized medicine (PPPM) is the hot spot and future
direction in the field of cancer. Cancer is a complex, whole-body disease that involved multi …

Background The poor prognosis and rising incidence of esophageal adenocarcinoma
highlight the need for improved detection methods. The potential for circulating microRNAs …